These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22162591)

  • 21. Treatment results of peritonectomy combined with perioperative chemotherapy for colorectal cancer-patients with peritoneal carcinomatosis.
    Yonemura Y; Ishibashi H; Sako S; Kitai T; Mizumoto A; Hirano M; Ichinose M; Takao N; Matsuda N; Togawa T; Ozamto Y; Chang-Yun L; Elnemr A; Li Y; Xiao-Jun Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):1987-91. PubMed ID: 22202261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
    Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
    Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases.
    Mulsow J; Merkel S; Agaimy A; Hohenberger W
    Br J Surg; 2011 Dec; 98(12):1785-91. PubMed ID: 22034185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
    Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
    World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Verwaal VJ, van Tinteren H, Ruth SV, et al.: Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004; 85:61-67.
    Sugarbaker PH
    J Surg Oncol; 2004 Dec; 88(4):276-8. PubMed ID: 15565559
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
    Verwaal VJ; van Tinteren H; Ruth SV; Zoetmulder FA
    J Surg Oncol; 2004 Feb; 85(2):61-7. PubMed ID: 14755505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evolving role of perioperative intraperitoneal chemotherapy after cytoreductive surgery for colorectal peritoneal carcinomatosis.
    Yan TD; Sugarbaker PH
    Ann Surg Oncol; 2007 Jul; 14(7):2171-2. PubMed ID: 17453299
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study.
    Chua TC; Morris DL; Saxena A; Esquivel J; Liauw W; Doerfer J; Germer CT; Kerscher AG; Pelz JO
    Ann Surg Oncol; 2011 Jun; 18(6):1560-7. PubMed ID: 21203904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis.
    Quenet F; Goéré D; Mehta SS; Roca L; Dumont F; Hessissen M; Saint-Aubert B; Elias D
    Ann Surg; 2011 Aug; 254(2):294-301. PubMed ID: 21772129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for the requirement of surgical or endoscopic interventions during chemotherapy in patients with uncomplicated colorectal cancer and unresectable synchronous metastases.
    Yun JA; Park Y; Huh JW; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
    J Surg Oncol; 2014 Dec; 110(7):839-44. PubMed ID: 25043872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Totally implantable systems in colorectal tumors. The locoregional chemotherapy of hepatic and peritoneal metastases].
    Ciaccio V; Bufalari A; Ferri M; Giustozzi GM
    Minerva Chir; 1992 Apr; 47(7):621-5. PubMed ID: 1589121
    [No Abstract]   [Full Text] [Related]  

  • 32. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
    Iversen LH; Rasmussen PC; Laurberg S
    Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.
    Shimizu T; Sonoda H; Murata S; Takebayashi K; Ohta H; Miyake T; Mekata E; Shiomi H; Naka S; Tani T
    Eur J Surg Oncol; 2014 May; 40(5):521-528. PubMed ID: 24388411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives?
    Sugarbaker PH
    Am J Surg; 2011 Feb; 201(2):157-9. PubMed ID: 20870209
    [No Abstract]   [Full Text] [Related]  

  • 35. Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Hingh IH; Creemers GJ
    Clin Colorectal Cancer; 2016 Jun; 15(2):e41-6. PubMed ID: 26762572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peritoneal carcinomatosis in patients with gastric cancer, and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy.
    Kim KW; Chow O; Parikh K; Blank S; Jibara G; Kadri H; Labow DM; Hiotis SP
    Am J Surg; 2014 Jan; 207(1):78-83. PubMed ID: 24157224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
    Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
    Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?
    Goéré D; Malka D; Tzanis D; Gava V; Boige V; Eveno C; Maggiori L; Dumont F; Ducreux M; Elias D
    Ann Surg; 2013 Jun; 257(6):1065-71. PubMed ID: 23299520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
    Glehen O; Kwiatkowski F; Sugarbaker PH; Elias D; Levine EA; De Simone M; Barone R; Yonemura Y; Cavaliere F; Quenet F; Gutman M; Tentes AA; Lorimier G; Bernard JL; Bereder JM; Porcheron J; Gomez-Portilla A; Shen P; Deraco M; Rat P
    J Clin Oncol; 2004 Aug; 22(16):3284-92. PubMed ID: 15310771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature.
    Ramírez-Plaza CP; Moreno-Ruiz FJ; Pérez-Daga JA
    World J Surg Oncol; 2015 Aug; 13():233. PubMed ID: 26231227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.